TGF-β maintains dormancy of prostatic stem cells in the proximal region of ducts

被引:100
作者
Salm, SN
Burger, PE
Coetzee, S
Goto, K
Moscatelli, D
Wilson, EL [1 ]
机构
[1] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Urol, New York, NY 10016 USA
[3] NYU, Sch Med, Kaplan Canc Ctr, New York, NY 10016 USA
[4] Borough Manhattan Community Coll, Dept Sci, New York, NY 10007 USA
[5] Univ Cape Town, Sch Med, Div Immunol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa
[6] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 8128582, Japan
关键词
D O I
10.1083/jcb.200412015
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously shown that prostatic stem cells are located in the proximal region of mouse prostatic ducts. Here, we show that this region responds differently to transforming growth factor (TGF)-beta than the distal ductal region and that under physiological conditions androgens and TGF-beta are crucial overall regulators of prostatic tissue homeostasis. This conclusion is supported by the observations showing that high levels of TGF-beta signaling are present in the quiescent proximal region of ducts in an androgen-replete animal and that cells in this region overexpress Bcl-2, which protects them from apoptosis. Moreover, androgen ablation W reverses the proximal-distal TGF-beta signaling gradient, leading to an increase in TGF-beta signaling in the unprotected distal region (low Bcl-2 expression). This reversal of TGF-beta-mediated signaling accompanies apoptosis of cells in the distal region and gland involution after androgen withdrawal. A physiological TGF-beta signaling gradient ( high proximally and low distally) and its functional correlates are restored after androgen replenishment. In addition to highlighting the regulatory role of androgens and TGF-beta, these findings may have important implications for the deregulation of the stem cell compartment in the etiology of proliferative prostatic diseases.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 51 条
[21]   Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression [J].
Kim, IY ;
Ahn, HJ ;
Zelner, DJ ;
Park, L ;
Sensibar, JA ;
Lee, C .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (01) :107-115
[22]  
Kundu SD, 2000, PROSTATE, V43, P118
[23]   Role of p63 and basal cells in the prostate [J].
Kurita, T ;
Medina, RT ;
Mills, AA ;
Cunha, GR .
DEVELOPMENT, 2004, 131 (20) :4955-4964
[24]   IDENTIFICATION OF A CELLULAR RECEPTOR FOR TRANSFORMING GROWTH FACTOR-BETA IN RAT VENTRAL PROSTATE AND ITS NEGATIVE REGULATION BY ANDROGENS [J].
KYPRIANOU, N ;
ISAACS, JT .
ENDOCRINOLOGY, 1988, 123 (04) :2124-2139
[25]   EXPRESSION OF TRANSFORMING GROWTH FACTOR-BETA IN THE RAT VENTRAL PROSTATE DURING CASTRATION-INDUCED PROGRAMMED CELL-DEATH [J].
KYPRIANOU, N ;
ISAACS, JT .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (10) :1515-1522
[26]   Apoptotic versus proliferative activities in human benign prostatic hyperplasia [J].
Kyprianou, N ;
Tu, HC ;
Jacobs, SC .
HUMAN PATHOLOGY, 1996, 27 (07) :668-675
[27]  
MASSAGUE J, 1991, CIBA F SYMP, V157, P51
[28]   The potential role of stem cell factor and its receptor c-kit in the mouse blastocyst implantation [J].
Mitsunari, M ;
Harada, T ;
Tanikawa, M ;
Iwabe, T ;
Taniguchi, F ;
Terakawa, N .
MOLECULAR HUMAN REPRODUCTION, 1999, 5 (09) :874-879
[29]   Latent transforming growth factor-beta: Structural features and mechanisms of activation [J].
Munger, JS ;
Harpel, JG ;
Gleizes, PE ;
Mazzieri, R ;
Nunes, I ;
Rifkin, DB .
KIDNEY INTERNATIONAL, 1997, 51 (05) :1376-1382
[30]  
Nemeth JA, 1996, PROSTATE, V28, P124